Loading...
Loading...
Living Homeopathy International Ltd.
Living Homeopathy International Ltd.. Spoken Alpha tracks LHI's earnings calls, guidance changes, and executive accountability over time.
Spoken Alpha tracks LHI's historical accountability: how often management beat consensus, how the stock reacted, and how guidance evolved across the cycle. The figures below are illustrative placeholder data generated for layout — they will be replaced with real deviation metrics, True Consensus values, and EODHD price reactions as those data layers land.
Misses consensus 10/10 quarters
SampleRepeated misses without a guidance reset suggest management is structurally optimistic relative to operating reality. Track whether next-quarter guidance is being benchmarked off the prior miss or the prior plan.
Missed in 4 of the last 4 quarters
SampleRecent misses matter more than long-window beat rate — the trailing 12 months drives the analyst model and the next-print bar.
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for LHI.
curl https://api.spokenalpha.com/v1/companies/LHI| Quarter | Actual EPS | Consensus | Surprise | 1D | 5D |
|---|---|---|---|---|---|
| Q1 FY2026 | $1.18 | $1.37 | -13.9% | -6.6% | -3.8% |
| Q4 FY2026 | $1.05 | $1.25 | -15.9% | +0.4% | +1.6% |
| Q3 FY2026 | $1.25 | $1.33 | -6.2% | -6.4% | -4.4% |
| Q2 FY2026 | $1.36 | $1.45 | -6.0% | +0.4% | +1.6% |
| Q1 FY2025 | $1.13 | $1.40 | -19.6% | -2.2% | -5.1% |
| Q4 FY2025 | $1.20 | $1.25 | -3.9% | -0.9% | +1.7% |
| Q3 FY2025 | $1.27 | $1.39 | -8.8% | -8.4% | -10.2% |
| Q2 FY2025 | $1.20 | $1.44 | -16.9% | -0.8% | -0.6% |
| Q1 FY2024 | $1.13 | $1.31 | -13.9% | -1.0% | -0.3% |
| Q4 FY2024 | $1.36 | $1.53 | -11.4% | -2.7% | -3.2% |